Chronic graft-versus-host disease (GvHD) affects 50% of long-term bone marrow transplant sur- vivors and remains a cause of major long-term morbidity in these patients despite aggressive therapy. Extracorporeal photochemotherapy (ECP), considered as an effective treatment for patients with erythrodermic cutaneous T-cell lymphoma (CTCL), has recently been used successfully in the treatment of GvHD. One of the most intriguing aspects of ECP is its ability to induce two apparently opposite effects: activation of the immune system against neoplastic cells (as in CTCL) and down- regulation of the activity of T-cell clones in autoimmune diseases (as in systemic sclerosis, systemic lupus erythematosus and pemphigus vulgaris) and autoallogeneic immune responses (as in GvHD and allograft rejection). Only a better and more complete understanding of the various mechanisms involved will enable this interesting new therapy to be made more effective and selective.

Fimiani, M., DI RENZO, M., Rubegni, P. (2004). Mechanism of action of extracorporeal photochemotherapy in chronic graft-versus-host disease. BRITISH JOURNAL OF DERMATOLOGY, 150(6), 1055-1060 [10.1111/j.1365-2133.2004.05918.x].

Mechanism of action of extracorporeal photochemotherapy in chronic graft-versus-host disease

FIMIANI, MICHELE;DI RENZO, MICHELA;RUBEGNI, PIETRO
2004-01-01

Abstract

Chronic graft-versus-host disease (GvHD) affects 50% of long-term bone marrow transplant sur- vivors and remains a cause of major long-term morbidity in these patients despite aggressive therapy. Extracorporeal photochemotherapy (ECP), considered as an effective treatment for patients with erythrodermic cutaneous T-cell lymphoma (CTCL), has recently been used successfully in the treatment of GvHD. One of the most intriguing aspects of ECP is its ability to induce two apparently opposite effects: activation of the immune system against neoplastic cells (as in CTCL) and down- regulation of the activity of T-cell clones in autoimmune diseases (as in systemic sclerosis, systemic lupus erythematosus and pemphigus vulgaris) and autoallogeneic immune responses (as in GvHD and allograft rejection). Only a better and more complete understanding of the various mechanisms involved will enable this interesting new therapy to be made more effective and selective.
Fimiani, M., DI RENZO, M., Rubegni, P. (2004). Mechanism of action of extracorporeal photochemotherapy in chronic graft-versus-host disease. BRITISH JOURNAL OF DERMATOLOGY, 150(6), 1055-1060 [10.1111/j.1365-2133.2004.05918.x].
File in questo prodotto:
File Dimensione Formato  
Mechanism of action of extracorporeal photochemotherapy in chronic graft-versus-host disease.pdf

non disponibili

Tipologia: Post-print
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 86.94 kB
Formato Adobe PDF
86.94 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/24573
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo